The Division Bench dismissed the connected writ appeals, while making a limited modification to the Single Judge’s findings concerning the Bar Council of Kerala. In light of…
PharmEasy Sells 10% Stake In Thyrocare For ₹668 Cr
Update / Judgement Date
26 Oct 2025
Source
Author
Team — WCP Legal Desk
Reading Time
1 min read
View Count
PharmEasy has sold a 10% stake in its diagnostics arm, Thyrocare Technologies, for approximately ₹668 crore. The divestment aims to strengthen liquidity and balance sheet stability while focusing on the company’s core digital healthcare and telemedicine operations. This move is part of PharmEasy’s broader restructuring and capital optimization efforts amid changing investor dynamics.